InfuSystem Holdings, Inc. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, listed on NYSE American under the ticker INFU.
Bain Capital Specialty Finance, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a decline in net asset value per share and total net assets compared to year-end 2025.
Puma Biotechnology, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net product revenue of $54.1 million and nine-month income from operations of $9.031 million.
Bain Capital Specialty Finance, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing the appointment of Amrit Kanwal as an independent Class III director, a bylaw amendment expanding the board from eight to nine members, Q3 2026 financial results, and …
Director Amrit Kanwal filed a Form 3 initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing holdings in Bain Capital Specialty Finance, Inc. as of a triggering event dated November 4, 2026.
The Baldwin Insurance Group, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing financial results, capital structure details, and an ongoing go-private transaction that would delist its Class A common stock from Nasdaq.
Perspective Therapeutics, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing its financial results for the quarter ended September 30, 2026, along with an updated corporate presentation posted the same day.
HF Foods Group Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net loss attributable to the company of $4,222 thousand for the third quarter.
Digital Turbine, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting second-quarter net revenue of $178.7 million and net income of $10.3 million.
DocGo Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the quarterly period ended September 30, 2026, reporting continued operating losses and a decline in total assets compared to year-end 2025.